fda green list glp-1 launches "Green List" to protect consumers from illegal drug imports | Blank Rome LLP posted on the topic GLP-1 Pipeline Update: May 2026

Lisa Tritto is a board-certified pediatrician and pediatric and adolescent weight loss specialist

FDA have issued safety alerts about compounded GLP-1 products, including reports of dose errors, sterility issues and active ingredients that did not match the label

C., Cariou, B., Pileti, M., Rose, L., Axelsen, M., Rowe, E., & DeVries, J

However, the patent term on the main compound has been extended by over five years as a result of a Patent Term Adjustment (PTA) and a Patent Term Extension (PTE)

Nisha Dahiya +2 more Table of Contents Starting glucagon-like peptide-1 (GLP-1) medicine for weight loss can provide a sense of hope and motivation, as the journey toward better weight control and health begins